Purchases and Sales Made in Q1 2024 in Relay Therapeutics, Inc. (RLAY)
This table provides information about the institutional ownership of Relay Therapeutics, Inc. (RLAY) during Q1 2024. The information is specifically focused on institutions that hold shares of Relay Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Oct 17, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-85.3K- 6.86% |
$639K - $1.03M
|
1.16M
$4.41M
|
|
May 13, 2024
Q1 2024
|
Jefferies Financial Group Inc.
New York, NY |
SELL
|
- |
-108K- 51.47% |
$808K - $1.3M
|
102K
$387K
|
|
May 08, 2024
Q1 2024
|
Td Asset Management Inc
|
SELL
|
- |
-109K- 23.36% |
$820K - $1.32M
|
359K
$1.37M
|
|
May 15, 2024
Q1 2024
|
Caxton Associates LP
New York, NY |
SELL
|
- |
-148K- 53.13% |
$1.11M - $1.79M
|
131K
$498K
|
|
May 15, 2024
Q1 2024
|
Barclays PLC
London, X0 |
SELL
|
- |
-155K- 52.51% |
$1.16M - $1.87M
|
140K
$533K
|
|
May 14, 2024
Q1 2024
|
Rhenman & Partners Asset Management Ab
Stockholm, V7 |
SELL
|
- |
-160K- 41.03% |
$1.2M - $1.93M
|
230K
$876K
|
|
May 15, 2024
Q1 2024
|
Driehaus Capital Management LLC
Chicago, IL |
SELL
|
- |
-195K- 32.9% |
$1.46M - $2.35M
|
398K
$1.52M
|
|
May 03, 2024
Q1 2024
|
Candriam S.C.A.
|
SELL
|
- |
-213K- 29.49% |
$1.59M - $2.57M
|
508K
$1.94M
|
|
May 15, 2024
Q1 2024
|
Ubs Asset Management Americas Inc
Chicago, IL |
SELL
|
- |
-285K- 33.8% |
$2.13M - $3.43M
|
557K
$2.12M
|
|
May 15, 2024
Q1 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-360K- 60.31% |
$2.7M - $4.35M
|
237K
$904K
|
|
May 15, 2024
Q1 2024
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-1.7M- 19.83% |
$12.8M - $20.5M
|
6.88M
$26.2M
|
|
Dec 26, 2024
Q1 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-1.8M- 32.63% |
$13.5M - $21.7M
|
3.72M
$14.2M
|
|
May 10, 2024
Q1 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-2.35M- 38.72% |
$17.6M - $28.3M
|
3.72M
$14.2M
|